YuanMing Prudence Fund

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 18, 2020	CANbridge Pharmaceuticals	$98.0M Series D	Lefei Sun, WuXi AppTec	Hudson Bay Capital, Derek DiRocco, Tigermed
Jul 18, 2018	Ascentage Pharma	$150.0M Series C	Teng Yue Partners, Lawrence Tian	ArrowMark Partners, CCB International, CTS Capital, HDY International Investment

Total Raised

N/A

Valuation

N/A